Detalhe da pesquisa
1.
Minimum and Optimal CA19-9 Response After Two Months Induction Chemotherapy in Patients With Locally Advanced Pancreatic Cancer: A Nationwide Multicenter Study.
Ann Surg
; 279(5): 832-841, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37477009
2.
Impact of 18FFDG-PET/CT and Laparoscopy in Staging of Locally Advanced Gastric Cancer: A Cost Analysis in the Prospective Multicenter PLASTIC-Study.
Ann Surg Oncol
; 31(6): 4005-4017, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38526832
3.
Measurement of metabolite levels and treatment-induced changes in hepatic metastases of gastro-esophageal cancer using 7-T phosphorus magnetic resonance spectroscopic imaging.
NMR Biomed
; : e5155, 2024 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38616046
4.
31 P MR Spectroscopy in the Pancreas: Repeatability, Comparison With Liver, and Pilot Pancreatic Cancer Data.
J Magn Reson Imaging
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485455
5.
SOURCE beyond first-line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first-line palliative systemic therapy.
Int J Cancer
; 152(6): 1202-1209, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36451334
6.
Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: A population-based study.
Int J Cancer
; 153(1): 33-43, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36855965
7.
Long-term health-related quality of life in patients with advanced esophagogastric cancer receiving first-line systemic therapy.
Support Care Cancer
; 31(9): 520, 2023 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37578590
8.
Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis.
Ann Surg
; 275(4): 769-775, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32773631
9.
Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinoma.
HPB (Oxford)
; 24(4): 535-546, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642090
10.
Nationwide treatment and outcomes of perihilar cholangiocarcinoma.
Liver Int
; 41(8): 1945-1953, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33641214
11.
SOURCE: Prediction Models for Overall Survival in Patients With Metastatic and Potentially Curable Esophageal and Gastric Cancer.
J Natl Compr Canc Netw
; 19(4): 403-410, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33636694
12.
Readily available biomarkers predict poor survival in metastatic pancreatic cancer.
Biomarkers
; 26(4): 325-334, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33663300
13.
Preoperative serum ADAM12 levels as a stromal marker for overall survival and benefit of adjuvant therapy in patients with resected pancreatic and periampullary cancer.
HPB (Oxford)
; 23(12): 1886-1896, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34103247
14.
Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study.
Int J Cancer
; 146(7): 1889-1901, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340065
15.
Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer: a prospective study with weekly MRI.
Acta Oncol
; 59(7): 753-759, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32400242
16.
Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis.
Acta Oncol
; 59(6): 705-712, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32056483
17.
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study.
Gastric Cancer
; 23(4): 579-590, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31927675
18.
The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis.
HPB (Oxford)
; 22(2): 233-240, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31439478
19.
Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial.
Ann Surg
; 269(4): 621-630, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30308612
20.
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)
BMC Cancer
; 19(1): 390, 2019 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31023318